Agra Ventures Ltd.
Agra Ventures Ltd.
Your view on AGRA.CN
Overview
What the company does, where it operates, and who runs it.
About Agra Ventures Ltd.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nicholas J. Kuzyk
- Headquarters
- CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Nicholas J. Kuzyk
- Headquarters
- CA
Agra Ventures Ltd. operates in the cannabis industry in Canada and Germany. The company engages in the cultivation, distribution, and marketing of high-quality cannabis and cannabis-infused products.
It manufactures, processes, and distributes soft gels, tinctures, distillates, and THC oils, as well as edibles, cosmetics, beverages, CBD performance, and pet products.
The company was formerly known as AgraFlora Organics International Inc. and changed its name to Agra Ventures Ltd. in July 2021. Agra Ventures Ltd. was incorporated in 2004 and is headquartered in Vancouver, Canada.
Past Reports
Historical coverage archive.
*Agra Ventures Ltd. had paid FRC a fee for research coverage and distribution of reports. This fee creates a potential conflict of interest which readers should consider.
Q2 Revenue up 25% QoQ; Sale from harvest expected in Q1 2021
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Agra Ventures Ltd.. Starting points for Agra Ventures Ltd.: EPS -C$0.74, beta 1.21 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Agra Ventures Ltd.. Agra Ventures Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Agra Ventures Ltd.. Trailing twelve-month EPS for Agra Ventures Ltd. stands at -C$0.74. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Agra Ventures Ltd.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CPIXCumberland Pharmaceuticals Inc. | Healthcare | NASDAQ | $98.5M | ||
| CPMDCannaPharmaRX, Inc. | Healthcare | OTC | $2.0M | ||
| AAWHAscend Wellness Holdings, Inc. | Healthcare | OTC | $114.1M | ||
| ABSCFAB Science S.A. | Healthcare | OTC | $96.0M | ||
| ABTIAlterola Biotech, Inc. | Healthcare | OTC | $7.4M | ||
| ACBAurora Cannabis Inc. | Healthcare | NASDAQ | $289.3M | ||
| ACB.TOAurora Cannabis Inc. | Healthcare | TSX | $414.8M | ||
| ACURAcura Pharmaceuticals, Inc. | Healthcare | OTC | $33,001 | ||
| ACUSAcusphere, Inc. | Healthcare | OTC | $49 | ||
| AFP.AXAFT Pharmaceuticals Limited | Healthcare | ASX | — | ||
| AGFAFDigicann Ventures Inc. | Healthcare | OTC | $606,354 | ||
| AGYTFAllergy Therapeutics plc | Healthcare | OTC | $504.6M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Agra Ventures Ltd.. Coverage tracks Agra Ventures Ltd. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Agra Ventures Ltd.